Publication | Closed Access

Randomized, placebo-controlled study of Lamifiban with thrombolytic therapy for the treatment of acute myocardial infarction: Rationale and design for the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) study

ThrombosisReperfusion GainCardiovascular DiseaseBlood PlateletMedicinePlacebo-controlled StudyPharmacotherapyPlatelet AntagonistPharmacologyAnticoagulantCardiologyAcute Myocardial InfarctionMyocardial Infarction